The BriefBrief · Intelligence, not news.
Download on the App Store Get it on Google Play
Top Stories World US Deutschland Россия Sports Business Weather Local Messages My Briefs
Event Brief
UPDATED Jun 1, 2026 at 9:00 PM ET
May 29, 2026 at 7:04 PM ET

Experimental daraxonrasib pill extends survival in pancreatic cancer

By The BriefBrief
A trial found daraxonrasib nearly doubled survival for advanced pancreatic cancer patients with fewer severe side effects.
WHO: Dr. Zev Wainberg, University of California, Los Angeles
WHAT: Researchers reported that the experimental pill daraxonrasib nearly doubled survival time in a randomized study of advanced pancreatic cancer patients.
WHEN: May 31, 2026 at 9:00 AM ET
WHERE: USA
WHY: The drug blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases.
How this story developed (showing 3 of 3 earlier reports)

Reporting from 5 identified publishers across this event arc.

View all 5 publishers
Publishers represented across this event arc

These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.
Four villagers evacuated from flooded Laos cave
World May 31, 2026 at 11:03 AM ET
Netanyahu vows to expand Israel’s grip on Lebanon
Middle-East May 31, 2026 at 11:02 AM ET
Trump proposes himself after artists cancel 250th event
Donald Trump May 31, 2026 at 11:02 AM ET
Coastal showers continue through the morning
Tampa Bay May 31, 2026 at 11:00 AM ET

Page 16991 of 21449

Same format. Every time.

Continue reading — sign in or create a free account with

G Google  Apple or email